Raptiva

In the US, Raptiva (efalizumab systemic) is a member of the drug class selective immunosuppressants and is used to treat Psoriasis.

US matches:

• Raptiva

Ingredient matches for Raptiva

Efalizumab

Efalizumab is reported as an ingredient of Raptiva in the following countries:

• Argentina


• Australia


• Brazil


• Bulgaria


• Canada


• Croatia (Hrvatska)


• Denmark


• Hong Kong


• Iceland


• Israel


• Norway


• Oman


• Serbia


• Singapore


• Slovenia


• Turkey


• United States

International Drug Name Search